product summary
Loading...
company name :
OriGene
product type :
antibody
product name :
NLRX1 Rabbit Polyclonal Antibody
catalog :
TA337151
quantity :
100 µg
price :
457 USD
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human
application :
western blot, immunohistochemistry
more info or order :
product information
SKU :
TA337151
Category :
Antibodies
Sub-Category :
Primary Antibodies
Name :
NLRX1 Rabbit Polyclonal Antibody
Description :
Rabbit Polyclonal NLRX1 Antibody
Size :
100 µg
Price US :
457 USD
Delivery Time US :
5 Days
Symbol :
NLRX1
Uniprot ID :
Q86UT6
Accn :
NM_024618
Clonality :
Polyclonal
Host :
Rabbit
Applications :
IHC, WB
Reactivity :
Equine, Human, Mouse, Primate, Rat
more info or order :
company information

OriGene
9620 Medical Center Dr., Suite 200
Rockville, MD 20850
Rockville, MD 20850
custsupport@origene.com
https://www.origene.com1-888-267-4436
headquarters: USA
OriGene Technologies, Inc. is a gene centric life sciences company dedicated to support biomedical scientists in gene functions and drug discovery. OriGene’s novel product line includes the world’s largest collections of cDNA clones (TrueClone and TrueORF), shRNA (HuSH-29), purified human recombinant proteins, high quality TrueMAB™ monoclonal antibodies to human proteins, 100,000 highly validated human tissues, and qPCR arrays. OriGene also provides a broad range of antibody validation products including genome-wide tagged antigen standards and extensive IHC slides derived from our tissue collection. OriGene is a Luminex Certified Partner™ and offers multiplexed immunoassays and multiplexed assays for a broad range of biomarkers.
related products
browse more products
- EPS8 Mouse Monoclonal Antibody [Clone ID: 18F1F2] | TA337153
- IL17E (IL25) Mouse Monoclonal Antibody [Clone ID: 8B1] | TA337154
- IL17F Mouse Monoclonal Antibody [Clone ID: 4H1629] | TA337155
- CRLF2 Mouse Monoclonal Antibody [Clone ID: 59N5G4] | TA337156
- TLR7 Mouse Monoclonal Antibody [Clone ID: 4G6] | TA337157
questions and comments